AngioDynamics (ANGO) Insider Trading & Ownership $11.14 +0.02 (+0.18%) Closing price 04:00 PM EasternExtended Trading$11.14 0.00 (0.00%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AngioDynamics (NASDAQ:ANGO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$608.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$49.98K Get ANGO Insider Trade Alerts Want to know when executives and insiders are buying or selling AngioDynamics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANGO Insider Buying and Selling by Quarter AngioDynamics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/16/2025Debbie Wasserman SchultzU.S. Congress Member (D-FL)Sell$8.60$1,001 - $15,0006/27/2025Debbie Wasserman SchultzU.S. Congress Member (D-FL)Buy$9.78$1,001 - $15,0001/16/2025Warren Nighan JrSVPSell4,060$12.31$49,978.60 10/10/2024Warren Nighan JrSVPBuy100$6.08$608.00 (Data available from 1/1/2013 forward) ANGO Insider Trading Activity - Frequently Asked Questions Who is on AngioDynamics' Insider Roster? The list of insiders at AngioDynamics includes Dave Helsel, James C Clemmer, Stephen A Trowbridge, and Warren Nighan Jr. Learn more on insiders at ANGO. What percentage of AngioDynamics stock is owned by insiders? 6.00% of AngioDynamics stock is owned by insiders. Learn more on ANGO's insider holdings. Which AngioDynamics insiders have been buying company stock? The following insiders have purchased ANGO shares in the last 24 months: James C Clemmer ($187,600.00), Stephen A Trowbridge ($9,962.00), and Warren Nighan Jr ($5,285.12). How much insider buying is happening at AngioDynamics? Insiders have purchased a total of 32,568 ANGO shares in the last 24 months for a total of $202,847.12 bought. Which AngioDynamics insiders have been selling company stock? The following insider sold ANGO shares in the last 24 months: Warren Nighan Jr ($49,978.60). How much insider selling is happening at AngioDynamics? Insiders have sold a total of 4,060 AngioDynamics shares in the last 24 months for a total of $49,978.60 sold. Which members of congress are trading AngioDynamics? Debbie Wasserman Schultz (D-FL) has bought shares of AngioDynamics in the last year totaling $8,000. Debbie Wasserman Schultz (D-FL) has sold shares totaling $8,000. AngioDynamics Key ExecutivesMr. James C. Clemmer (Age 60)CEO, President & Director Compensation: $982.92kMr. Stephen A. Trowbridge (Age 50)Executive VP & CFO Compensation: $528.02kMr. Chad T. Campbell (Age 53)Senior VP and GM of Global Vascular Access & Oncology Global Business Unit Compensation: $416.51kMs. Laura Piccinini (Age 55)Senior VP & GM of Endovascular Therapies and International Compensation: $444.31kMr. Saleem M. CheeksVice President of CommunicationsMr. Benjamin H. Davis (Age 60)Senior Vice President of Business Development Ms. Marna I. Bronfen-Moore (Age 57)Senior Vice President of Human Resources Mr. Warren G. Nighan (Age 55)Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain Compensation: $622.11kMs. Kim L. Seabury (Age 57)Senior Vice President of Information Technology Mr. Juan Carlos SernaSenior Vice President of Scientific & Clinical Affairs More Insider Trading Tools from MarketBeat Related Companies TMO Insider Ownership WST Insider Ownership ATRC Insider Ownership IART Insider Ownership OFIX Insider Ownership SRDX Insider Ownership ARAY Insider Ownership RMTI Insider Ownership ABT Insider Ownership ISRG Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:ANGO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
